1. Home
  2. VIAV vs VERA Comparison

VIAV vs VERA Comparison

Compare VIAV & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viavi Solutions Inc.

VIAV

Viavi Solutions Inc.

HOLD

Current Price

$26.43

Market Cap

4.1B

Sector

Technology

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$42.73

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIAV
VERA
Founded
1923
2016
Country
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VIAV
VERA
Price
$26.43
$42.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
11
Target Price
$20.91
$76.60
AVG Volume (30 Days)
5.5M
1.0M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$37.78
N/A
Revenue Next Year
$10.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.10
$18.53
52 Week High
$28.15
$56.05

Technical Indicators

Market Signals
Indicator
VIAV
VERA
Relative Strength Index (RSI) 69.19 43.68
Support Level $25.55 $41.46
Resistance Level $28.15 $44.03
Average True Range (ATR) 1.58 2.19
MACD 0.08 -0.24
Stochastic Oscillator 77.27 29.61

Price Performance

Historical Comparison
VIAV
VERA

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: